Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-111
BPC-157 10mg + TB-500 10mg 10mg + 10mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-111
Active Batch Lot
Recovery & Tissue Repair • In stock — Ready to ship

BPC-157 10mg + TB-500 10mg (10mg + 10mg)

€95 10mg + 10mg • EUR
Related Formats: BPC-157 10mg + TB-500 10mg (10mg + 10mg) BPC-157 5mg + TB-500 5mg (5mg + 5mg) — €56

High-concentration co-lyophilized dual-peptide vial combining 10 mg BPC-157 and 10 mg TB-500 (20 mg total active peptide), verified via dual-peak RP-HPLC integration for synergistic tissue-repair research models.

Chemical & Registry Specifications
CAS Registry Number 137525-51-0 / 77591-33-4
Molecular Formula C62H98N16O22 + C212H350N56O78S
Molecular Weight 1419.53 g/mol & 4963.50 g/mol
Counterion / Form Acetate lyophilized blend
Sequence / Structural Class Co-lyophilized BPC-157 (15-aa) + Thymosin β4 / TB-500 (43-aa)
Primary Biological Target / Pathway Dual VEGFR2/NO angiogenesis & G-actin sequestration pathways
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: BPC-157 10mg + TB-500 10mg

High-concentration co-lyophilized dual-peptide vial combining 10 mg BPC-157 and 10 mg TB-500 (20 mg total active peptide), verified via dual-peak RP-HPLC integration for synergistic tissue-repair research models.

Dual-peak RP-HPLC verification of both BPC-157 & TB-500
1:1 stoichiometric mass ratio (10 mg + 10 mg)
Eliminates multi-vial pipetting variance in synergy assays
Primary Literature Reference Sikiric P. et al., Curr Pharm Des (2018) & Goldstein A.L. et al., Expert Opin Biol Ther (2012) — Complementary angiogenic and actin-remodeling models

Active Batch Release Specifications (Lot SL-2026-111)

Analytical release verification for current BPC-157 10mg + TB-500 10mg (10mg + 10mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-111 2026-10-28 Gradient RP-HPLC (Multi-Peak Resolution) + ESI-MS ≥99.0% (Resolved Constituent Peaks) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water (2.0–3.0 mL); swirl gently without vortexing

Temperature & Stability

Store lyophilized blend at -20°C. Store reconstituted solution at 2°C–8°C and use within 28 days.

BPC-157 10mg + TB-500 10mg — Technical Questions & Answers

How are the individual constituents of BPC-157 10mg + TB-500 10mg verified in a single vial?

Because co-lyophilized blends contain multiple sequences with distinct retention times, Lot SL-2026-111 is evaluated via gradient RP-HPLC to resolve each constituent peak independently, paired with ESI-MS mass confirmation (1419.53 g/mol & 4963.50 g/mol).

How do you calculate working stock aliquots for a multi-component blend like BPC-157 10mg + TB-500 10mg?

Calculate each active constituent separately based on its labeled mass ratio (10mg + 10mg) divided by total diluent volume added. For example, adding 2.0 mL of sterile diluent yields proportional mg/mL concentrations for every component simultaneously.

What primary pathways are investigated using BPC-157 10mg + TB-500 10mg?

Investigators study BPC-157 10mg + TB-500 10mg in Dual VEGFR2/NO angiogenesis & G-actin sequestration pathways models. Primary published literature context: Sikiric P. et al., Curr Pharm Des (2018) & Goldstein A.L. et al., Expert Opin Biol Ther (2012) — Complementary angiogenic and actin-remodeling models. All lots are supplied strictly for in-vitro laboratory experimentation.

Research Use Only (RUO): BPC-157 10mg + TB-500 10mg is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related Recovery & Tissue Repair Compounds

View category →
≥99.0%
ARA 290 16 mg — ≥99.0% Research Vial
ARA 290
16 mg In stock
CAS 1208243-50-8
MW: 1257.31 g/mol
€52
≥99.2%
BPC-157 5 mg — ≥99.2% Research Vial
BPC-157
5 mg In stock
CAS 137525-51-0
MW: 1419.53 g/mol
€38
≥99.0%
BPC-157 5mg + TB-500 5mg 5mg + 5mg — ≥99.0% Research Vial
BPC-157 5mg + TB-500 5mg
5mg + 5mg In stock
CAS 137525-51-0 / 77591-33-4
MW: 1419.53 g/mol & 4963.50 g/mol
€56
≥99.0%
KPV 10 mg — ≥99.0% Research Vial
KPV
10 mg In stock
CAS 67727-97-3
MW: 342.43 g/mol
€42

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog